Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :25402202
Publication Date : //

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.

Paclitaxel exhibits clinical activity against a wide variety of solid tumors. However, resistance to paclitaxel significantly attenuates the response to chemotherapy. The ABC transporter subfamily C member 10 (ABCC10), also known as multi-drug resistance protein 7 (MRP7) efflux transporter, is a major mediator of paclitaxel resistance. Here, we determine the effect of NVP-BHG712, a specific EphB4 receptor inhibitor, on 1) paclitaxel resistance in HEK293 cells transfected with ABCC10, 2) the growth of tumors in athymic nude mice that received NVP-BHG712 and paclitaxel systemically and 3) the pharmacokinetics of paclitaxel in presence or absence of NVP-BHG712. NVP-BHG712 (0.5 μM), in HEK293/ABCC10 cells, significantly enhanced the intracellular accumulation of paclitaxel by inhibiting the efflux activity of ABCC10 without altering the expression level of the ABCC10 protein. Furthermore, NVP-BHG712 (25 mg/kg, p.o., q3d x 6), in combination with paclitaxel (15 mg/kg, i.p., q3d x 6), significantly inhibited the growth of ABCC10-expressing tumors in athymic nude mice. NVP-BHG712 administration significantly increased the levels of paclitaxel in the tumors but not in plasma compared to paclitaxel alone. The combination of NVP-BHG712 and paclitaxel could serve as a novel and useful therapeutic strategy to attenuate paclitaxel resistance mediated by the expression of the ABCC10 transporter.

Authors : Kathawala Rishil J , Wei Liuya , Anreddy Nagaraju , Chen Kang , Patel Atish , Alqahtani Saeed , Zhang Yun-Kai , Wang Yi-Jun , Sodani Kamlesh , Kaddoumi Amal , Ashby Charles R , Chen Zhe-Sheng ,

Related products :

Catalog number Product name Quantity
orb60831 NVP-BHG712 NVP-BHG712 is a small molecule specific EphB4, VEGFR2, c-raf, c-src and c-Abl kinase inhibitor with ED50 of 25 nM, 4.2, 0.4, 1.3 and 1.7 10 mg
orb61327 Dovitinib,Free Base Dovitinib is a small-molecule multitargeted receptor tyrosine kinase inhibitor. For research use only. 100 mg
orb61206 AC220 Quizartinib (AC220) is a small molecule receptor tyrosine kinase inhibitor that is currently under development for the treatment of acute myeloid leukaemia. For research use only. 500 mg
orb61290 Sunitinib (free base) Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by 100 mg
orb60207 XAV-939 XAV 939 is a small molecule and selective Wnt pathway transcription factor beta-catenin-mediated transcription inhibitor and axin stabilizing agent with IC50 of 11 and 4nM for the inhibition o 10 mg
PKI-AKT-005 Kinase inhibitors: Akt1_2 Inhibitor , small molecule, CAS number: na, Chemical name: Akt inhibitor VIII, AKT-I-1_2, 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4- 5 mg
orb60838 AZ 960 AZ 960 is a novel small molecule JAK2 kinase inhibitor with an IC50 and Ki of 3 mM and 0.45 nM in vitro, respectively. For research use only. 10 mg
PKI-FR1802-010 Kinase inhibitors: FR180204 , small molecule, CAS number: 865362-74-9 , Chemical name: ERK Inhibitor II 10 mg
orb60822 GSK461364 GSK 461364 is a potent small molecule Polo-like kinase 1 (PLK1) inhibitor with a Ki of 2.2 nM. For research use only. 10 mg
MD80001 MagCustom Feasibility Study, Bead development on client demand in small scale as feasability study 1 item
PKI-JNKI-001 Kinase inhibitors: JNK Inhibitor VIII (NEW), small molecule, CAS number: 894804-07-0, Chemical name: N-(4-Amino-5-cyano-6-ethoxy-2-pyridinyl)-2,5- dimethoxybenzeneacetamide 1 mg
PKI-ERK-005 Kinase inhibitors: Erk Inhibitor, small molecule, CAS number: 294675-79-9 (free base), Chemical name: 3-(2-Aminoethyl)-5-((4-ethoxyphenyl)methylene)-2,4-thiazolidinedione hydrochloride 5 mg
orb61342 GW2580, Free Base GW2580 is a small-molecule inhibitor of cFMS kinase; at 60 nM it inhibited human cFMS kinase completely in vitro and was inactive against 26 other kinases. For research use only. 300 mg
orb61226 BMS-777607 BMS 777607 is a Small-Molecule Met Kinase Inhibitor with an IC50 of < 0.1 5 mg
orb60514 BMS 777607 BMS 777607 is a Small-Molecule Met Kinase Inhibitor with an IC50 of < 0.1 10 mg
orb61299 Vatalanib Vatalanib is a small molecule protein kinase inhibitor that inhibits angiogenesis. For research use only. 10 mg
orb60812 LY2784544 LY2784544 is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM. For research use only. 10 mg
PKI-SRC-005 Kinase inhibitors: Src Inhibitor No.5 , small molecule, CAS number: na, Chemical name: 4-(3‘-Methoxy-6‘-chloro-anilino)-6-Methoxy-7-(Morpholino-3-propoxy)-quinazoline 5 mg
PKI-SRC-025 Kinase inhibitors: Src Inhibitor No.5 , small molecule, CAS number: na, Chemical name: 4-(3‘-Methoxy-6‘-chloro-anilino)-6-Methoxy-7-(Morpholino-3-propoxy)-quinazoline 25 mg
orb60464 AP24534 AP24534 is a novel potent, orally available small molecule multitargeted kinase inhibitor with IC50 of 0.37, 2, 1.5, 2.2, 1.1, 1and 0.24 nM for native pan-BCR-ABL, mutated form, VEGFR2, FGFR1, 25 mg
orb60146 PHA-739358 PHA-739358(Danusertib) is a pyrrolo-pyrazole and small molecule Aurora kinases and Bcr-Abl kinase inhibitor with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively. For research 5 mg
orb60101 Vandetanib Vandetanib is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectively. For rese 50 mg
orb61120 Vandetanib, Free Base Vandetanib is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9 cells and tyrosine kinase activity, respectivel 25 mg
EIAAB33008 CCK4,CCK-4,Colon carcinoma kinase 4,Homo sapiens,Human,Inactive tyrosine-protein kinase 7,Protein-tyrosine kinase 7,Pseudo tyrosine kinase receptor 7,PTK7,Tyrosine-protein kinase-like 7
U1915m CLIA Agammaglobulinaemia tyrosine kinase,ATK,B-cell progenitor kinase,BPK,Bpk,Bruton tyrosine kinase,Btk,Kinase EMB,Mouse,Mus musculus,Tyrosine-protein kinase BTK 96T


GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur

Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur



9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017


france@gentaur.com | Gentaur

Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123

GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

spain@gentaur.com | Gentaur

ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636

GENTAUR Poland Sp. z o.o.

ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556


Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur